Higher Titer of Anti-EBV Nuclear Antigen Antibodies Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified

MLA

Kusano, Yoshiharu, et al. “Higher Titer of Anti-EBV Nuclear Antigen Antibodies Might Be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified.” Blood, vol. 126, no. 23, Dec. 2015, p. 5016. EBSCOhost, https://doi.org/10.1182/blood.V126.23.5016.5016.

APA

Kusano, Y., Terui, Y., Ueda, K., Mishima, Y., Nishimura, N., Yokoyama, M., Nitta, H., Gunji, T., Inoue, N., Takahasi, A., Takeuchi, K., & Hatake, K. (2015). Higher Titer of Anti-EBV Nuclear Antigen Antibodies Might be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified. Blood, 126(23), 5016. https://doi.org/10.1182/blood.V126.23.5016.5016

Chicago

Kusano, Yoshiharu, Yasuhito Terui, Kyoko Ueda, Yuko Mishima, Noriko Nishimura, Masahiro Yokoyama, Hideaki Nitta, et al. 2015. “Higher Titer of Anti-EBV Nuclear Antigen Antibodies Might Be a Marker of Poorer Prognosis in Patients with Peripheral T-Cell Lymphoma, Not Otherwise Specified.” Blood 126 (23): 5016. doi:10.1182/blood.V126.23.5016.5016.